Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the efficacy and safety of generic semaglutide compared to innovator semaglutide in Indian adults with type 2 diabetes inadequately controlled on metformin, finding non-inferior results.
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
This study evaluated two health education apps for diabetes management, finding varying levels of user satisfaction and knowledge improvement.
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
This study investigated the effects of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic control in adult males with type 2 diabetes. It found no significant differences in key metabolic outcomes between the intervention and placebo groups.
This study evaluated the effects of metformin delayed-release on glycemic control in adults with type 2 diabetes, showing significant reductions in HbA1c and fasting plasma glucose compared to placebo.
This study evaluated the effectiveness of a mobile health social support program for diabetes management in emergency department patients, finding significant improvements in HbA1c levels.
The ASCEND PLUS trial evaluated oral semaglutide for preventing cardiovascular events in type 2 diabetes but found no significant benefits.
This study investigated the impact of a multi-strain probiotic supplement on various health outcomes in individuals with Type 2 diabetes, finding significant reductions in HbA1c, fasting plasma glucose, and total cholesterol.
This trial tested whether adults with prediabetes could start and maintain resistance training. After a supervised 3-month training phase, about one-third of participants were no longer prediabetic, and this was mostly maintained through 15 months. Extra social-cognitive support did not outperform lower-contact standard care.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
